MagNETIC
June 24, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Brain Health
MagNETIC is a Stanford University neurosurgery spinout developing a novel IV Magnesium Threonate formulation for neuroprotection across surgery, stroke, and antenatal settings - a $3.4B+ combined market with zero direct competitors. Backed by a 66-patient Stanford RCT led by the Stanford Stroke Centre, a filed patent and a 505(b)(2) regulatory pathway, MagNETIC addresses three markets with one formulation: perioperative neuroprotection in cerebral revascularization, stroke reperfusion therapy, and antenatal magnesium replacement. Developed through the Stanford SPARK translational research program, the planned NewCo will hold an exclusive Stanford license upon securing a $200K first-gate investment.
Company HQ City:
Palo Alto
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
Pending
CEO
Gary K. Steinberg
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}